Education
- Fellowship in Hematology and Medical Oncology
The University of Texas Southwestern Medical Center, Dallas, TX
- Residency in Internal Medicine
The University of Texas Southwestern Medical Center, Dallas, TX
- Medical Doctorate
Duke University, Durham, NC
Accolades & Memberships
Dr. Le is a member of the American Society of Hematology and the American Society of Clinical Oncology. He has authored and co-authored several publications in peer-reviewed journals and presented his work at numerous local and national conferences. His clinical excellence, commitment to teaching and mentorship, and leadership were recognized when he was selected as a chief resident and later, chief fellow at his training institutions.
- The University of Texas Southwestern Medical Center, Chief Fellow, Dallas, TX (2020 – 2021)
- Texas Society of Clinical Oncology Annual Conference, Outstanding Fellow Abstract (2019)
- The University of Texas Southwestern Medical Center, Medical Student Clerkship Teaching Award for Faculty, Dallas, TX (2018)
- Travel Grant for PRIME Oncology Young Investigator Forum (2018)
- The University of Texas Southwestern Medical Center, Chief Resident, Dallas, TX (2017 – 2018)
Publications
-
Covid-19 Associated Coagulopathy
Feature Article in the University of Texas Southwestern Covid-19 Action Newsletter, 2020
-
Checkpoint Inhibitor Pneumonitis: Too Clinically Serious For Benefit?
Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer, 2019
-
Improved Survival Outcomes for Kidney Cancer Patients with Brain Metastases
Clinical Genitourinary Cancer, 2019
-
Newer-Generation EGFR Inhibitors in Lung Cancer: How Are They Best Used?
Cancers, 2019
-
QTc Interval-Prolonging Medications Among Patients with Lung Cancer: Implications for Clinical Trial Eligibility and Clinical Care
Clinical Lung Cancer, 2019
Show all Publications
-
Prevalence and Significance of Drug-Drug Interactions Among Patients With Lung Cancer
Proceedings of the American Association for Cancer Research Annual Meeting 2019, 2019
-
Real World Outcomes of Nivolumab and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)
American Society of Clinical Oncology, 2018
-
Improved Survival Rates in Kidney Cancer Patients with Brain Metastases Treated with Modern Multidisciplinary Approaches
American Society of Clinical Oncology, 2018
-
Use of Qtc-prolonging Medications Among Patients With Lung Cancer: Implications for Clinical Trials and Standard Clinical Care
American Society of Clinical Oncology 2018 Annual Meeting, 2018
-
The Enrollment Status of Patients with Brain Metastases in Metastatic Renal Cell Carcinoma: A Query of clinicaltrials.gov
American Society of Clinical Oncology 2017 Annual Meeting, 2017
-
Anaplastic Lymphoma Kinase Alterations and Inhibition in Lung Cancer
Seminars in Cancer Biology, 2017
-
Upper Lip Metastasis of Sarcomatoid Carcinoma of the Lung - an Unusual Site of Disease: a Case Report
Journal of Medical Case Reports, 2017
-
Histologic Transformation of EGFR Mutant Lung Adenocarcinoma Without Wxposure to EGFR Inhibition
Lung Cancer, 2017
-
Incidence of Brain Metastases in Metastatic Renal Cell Carcinoma in the Era of Targeted Therapies
ASCO Annual Meeting, 2016
Show less publications